Gemifloxacin
Gemifloxacin, a fluoroquinolone, is a potent and orally active antipneumococcal agent. Gemifloxacin shows bactericidal activity against highly quinolone-resistant pneumococci.Gemifloxacin can be used for the research of respiratory infections, such as community-acquired pneumonia (CAP) and acute exacerbation of chronic bronchitis (AECB).
For research use only. We do not sell to patients.
- CAS No.: 175463-14-6
- Formula: C18H20FN5O4
- Molecular Weight:389.38
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Antibiotic Isoforms
More
Biological Activity
|
Quinolone |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HEp-2 | CC50 |
46 μM
Compound: GEM
|
Cytotoxicity against human Hep2 cell line after 72 hrs
Cytotoxicity against human Hep2 cell line after 72 hrs
|
[PMID: 17228862] |
| HEp-2 | CC50 |
46 μM
Compound: GEM
|
Cytotoxicity against human Hep2 cell line after 72 hrs
Cytotoxicity against human Hep2 cell line after 72 hrs
|
[PMID: 21443219] |
| HEp-2 | CC50 |
46 μM
Compound: gemifloxacin
|
Cytotoxicity against human Hep2 laryngeal carcinoma cell line
Cytotoxicity against human Hep2 laryngeal carcinoma cell line
|
[PMID: 16337791] |
| Hepatocyte | CC50 |
>100 μM
Compound: GEM
|
Cytotoxicity against rat hepatocytes after 48 hrs
Cytotoxicity against rat hepatocytes after 48 hrs
|
[PMID: 17228862] |
| HepG2 | CC50 |
35 μM
Compound: GEM
|
Cytotoxicity against human HepG2 cells after 72 hrs
Cytotoxicity against human HepG2 cells after 72 hrs
|
[PMID: 17228862] |
| HepG2 | IC50 |
13.49 μg/mL
Compound: Gemifloxacin (GMFX)
|
Cytotoxicity was determined for the compound in HepG2 cell line
Cytotoxicity was determined for the compound in HepG2 cell line
|
[PMID: 14980680] |
| MDCK | CC50 |
321 μM
Compound: GMFX
|
Cytotoxicity against MDCK cells after 48 hrs by CPE assay
Cytotoxicity against MDCK cells after 48 hrs by CPE assay
|
[PMID: 21481984] |
| V79-4 | IC50 |
10.08 μg/mL
Compound: Gemifloxacin (GMFX)
|
Cytotoxicity was determined for the compound in V79-4 cell line
Cytotoxicity was determined for the compound in V79-4 cell line
|
[PMID: 14980680] |
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 175463-14-6
-
Molecular Weight 389.38
-
Formula C18H20FN5O4
-
SMILES
NCC(C1)/C(CN1C(N=C2C(C(C(C(O)=O)=CN2C3CC3)=O)=C4)=C4F)=N/OC
-
Synonyms
SB-265805; LB20304
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Yoo BK, et al. Gemifloxacin: a new fluoroquinolone approved for treatment of respiratory infections. Ann Pharmacother. 2004 Jul-Aug;38(7-8):1226-35. [Content Brief]
[2]. Davies TA, et al. Antipneumococcal activities of gemifloxacin compared to those of nine other agents. Antimicrob Agents Chemother. 2000 Feb;44(2):304-10. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)